The effect of anti-tumor necrosis factor-alpha therapy within 12 weeks prior to surgery on postoperative complications in inflammatory bowel disease: a systematic review and meta-analysis

HIGHLIGHTS

• who: Kamacay Cira et al. from the Department of, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany have published the research work: The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis, in the Journal: (JOURNAL) of 17/02/2022
• what: The aim of this study was to evaluate the effect of anti-TNF-u03b1 treatment exclusively within the washout period of 12 weeks (3 months) prior to abdominal surgery, on a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.